Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, Zimmer Biomet Holdings stock has a consensus rating of "Hold" and an average price target of $98.05. The average 1-year stock price forecast is 7.35% higher than the current stock price, while the lowest is $83 (-9.13%) and the highest is $130 (+42.33%).

Price Target: $98.05 (+7.35%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$83	$98.05	$95	$130
Change	-9.13%	+7.35%	+4.01%	+42.33%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	6	6	6	6	6	6
Buy	3	2	2	2	2	2
Hold	17	17	17	17	17	18
Sell	1	1	1	0	0	0
Strong Sell	2	1	1	1	1	1
Total	29	27	27	26	26	27

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst BMO Capital No rating	BMO Capital	Hold Initiates $95	Hold	Initiates	$95	+4.01%	Jul 9, 2026
Joanne Wuensch Citi	Citi	Hold Maintains $93	Hold	Maintains	$93	+1.82%	Jul 8, 2026
Vijay Kumar Evercore ISI	Evercore ISI	Buy Maintains $120 → $110	Buy	Maintains	$120 → $110	+20.43%	Jul 6, 2026
Caitlin Roberts Canaccord Genuity	Canaccord Genuity	Hold Maintains $83	Hold	Maintains	$83	-9.13%	Jul 1, 2026
Ryan Zimmerman BTIG	BTIG	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jul 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

8.54B

from 8.23B

3.78%

from 8.23B

Revenue Next Year

8.84B

from 8.54B

3.44%

from 8.54B

EPS This Year

8.48

from 8.20

3.39%

from 8.20

EPS Next Year

8.99

from 8.48

6.04%

from 8.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.83B	6.94B	7.39B	7.68B	8.23B	8.54B
Revenue Growth	11.42%	1.65%	6.55%	3.85%	7.20%	3.78%
Gross Profit	4.87B	4.92B	5.32B	5.50B	5.74B	6.08B
Gross Margin	71.29%	70.90%	71.93%	71.61%	69.71%	71.15%
Operating Income	1.22B	1.29B	1.51B	1.59B	1.40B	2.31B
Net Income	401.60M	231.40M	1.02B	903.80M	705.10M	925.34M
EPS	-	-	-	-	8.20	8.48
EPS Growth	-	-	-	-	2.50%	3.39%
Forward PE	16.40	18.63	15.47	12.52	10.72	10.77
Dividend / Share	0.96	0.96	0.96	0.96	0.96	1.03
Dividend Growth	-	-	-	-	-	7.20%
Free Cash Flow	891.55M	1.65B	1.13B	1.06B	1.35B	1.29B
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	8.6B
Avg	8.5B
Low	8.4B

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.4%
Avg	3.8%
Low	2.3%

EPS Forecast

EPS	2026	2027	2028
High	8.53
Avg	8.48
Low	8.35

EPS Growth

EPS Growth	2026	2027	2028
High	4.0%
Avg	3.4%
Low	1.8%